New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Sonnet BioTherapeutics Holdings, Inc.
SONN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

3M

Biotechnology

Next Earning date - 12 Dec 2024

3M

Biotechnology

Next Earning date - 12 Dec 2024

4.97USD
Shape-1.03 ( -17.17%)
favorite-chart

Relative Strenght

12
favorite-chart

Volume Buzz

508%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

73%

Quote Panel

Shape
Updated October 28, 2024
1W -19.84 % 1M -26.91 % 3M -28.61 % 1Y -50.71 %

Key Metrics

Shape
  • Market Cap

    3.23M


  • Shares Outstanding

    650313


  • Share in Float

    614740


  • Dividende

    0


  • Earning Date

    12 Dec 2024


  • Price Target

    4.97


  • Average Volume

    27565


  • Beta

    1.004


  • Range

    4.3-18.72


  • Industry

    Biotechnology


  • Website

    https://www.sonnetbio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

69.94x

P/S Ratio

11.56x

P/B Ratio

0.1

Debt/Equity

-14290.0%

Net Margin

$-1.0

EPS

How SONN compares to sector?

P/E Ratio

Relative Strength

Shape

SONN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$43K

ShapeNaN%

2025-Revenue

$1.87

Shape-167%

2025-EPS

$18K

Shape99%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

BTIG

initialise

Previous: Not converted

2021-09-15

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-1.67
vs -2.45

Q4.22

arrow
arrow

N/A

-17.58
vs -30.78

Q1.23

arrow
arrow

N/A

-7.47
vs -43.09

Q2.23

arrow
arrow

N/A

-2.86
vs -1.82

Q3.23

arrow
arrow

N/A

-2.09
vs -1.67

Q4.23

arrow
arrow

N/A

-0.31
vs -17.58

Q1.24

arrow
arrow

+101%

0.07
vs -7.47

Q2.24

arrow
arrow

N/A

-5.60
vs -2.86

Q3.24

arrow
arrow

N/A

-5.04
vs -2.09

Q4.24

arrow
arrow

N/A

-4.16
vs -0.31

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

62.1K  vs NA

Q3.22

arrow
arrow

-87%

62.8K  vs 483.6K

Q4.22

arrow
arrow

-71%

37.3K  vs 129.8K

Q1.23

arrow
arrow

-62%

36.4K  vs 95.3K

Q2.23

arrow
arrow

-41%

36.9K  vs 62.1K

Q3.23

arrow
arrow

-41%

37.3K  vs 62.8K

Q4.23

arrow
arrow

-50%

18.6K  vs 37.3K

Q1.24

arrow
arrow

-100%

NA  vs 36.4K

Q2.24

arrow
arrow

-100%

NA  vs 36.9K

Q3.24

arrow
arrow

-25%

28K  vs 37.3K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+295%

2.95
vs -10.32

Q4.22

arrow
arrow

+155%

1.55
vs 2.95

Q1.23

arrow
arrow

-106%

-1.06
vs 1.55

Q2.23

arrow
arrow

-115%

-1.15
vs -1.06

Q3.23

arrow
arrow

+1627%

16.27
vs -1.15

Q4.23

arrow
arrow

-45%

-0.45
vs 16.27

Q1.24

arrow
arrow

+12%

0.12
vs -0.45

Q2.24

arrow
arrow

-134%

-1.34
vs 0.12

Institutionnal OwnershipShape

status-upQoQ

Q4.20

arrow
arrow

9

9
vs 9

NA

Q1.21

arrow
arrow

15

15
vs 9

67%

Q2.21

arrow
arrow

10

10
vs 15

-33%

Q3.21

arrow
arrow

13

13
vs 10

30%

Q4.21

arrow
arrow

16

16
vs 13

23%

Q1.22

arrow
arrow

21

21
vs 16

31%

Q2.22

arrow
arrow

18

18
vs 21

-14%

Q3.22

arrow
arrow

1

1
vs 18

-94%

Earnings Growth

Latest News